Citadel Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.9M | Sell |
211,500
-243,800
| -54% | -$80.1M | 0.01% | 1163 |
|
|
2025
Q4 | $160M | Sell |
455,300
-28,400
| -6% | -$9.6M | 0.02% | 594 |
|
|
2025
Q3 | $156M | Buy |
483,700
+102,700
| +27% | +$31.9M | 0.02% | 594 |
|
|
2025
Q2 | $148M | Buy |
381,000
+67,600
| +22% | +$27.2M | 0.03% | 528 |
|
|
2025
Q1 | $136M | Buy |
313,400
+57,300
| +22% | +$23M | 0.03% | 526 |
|
|
2024
Q4 | $94.5M | Buy |
256,100
+82,900
| +48% | +$34.7M | 0.02% | 770 |
|
|
2024
Q3 | $90.1M | Sell |
173,200
-1,700
| -1% | -$908K | 0.02% | 760 |
|
|
2024
Q2 | $94.8M | Sell |
174,900
-113,400
| -39% | -$59.9M | 0.02% | 714 |
|
|
2024
Q1 | $149M | Sell |
288,300
-205,500
| -42% | -$102M | 0.03% | 498 |
|
|
2023
Q4 | $233M | Buy |
493,800
+307,000
| +164% | +$142M | 0.05% | 295 |
|
|
2023
Q3 | $81.3M | Sell |
186,800
-58,500
| -24% | -$26.5M | 0.02% | 741 |
|
|
2023
Q2 | $109M | Buy |
245,300
+84,900
| +53% | +$39.2M | 0.02% | 564 |
|
|
2023
Q1 | $73.8M | Sell |
160,400
-117,500
| -42% | -$55.9M | 0.02% | 793 |
|
|
2022
Q4 | $143M | Sell |
277,900
-321,800
| -54% | -$163M | 0.03% | 481 |
|
|
2022
Q3 | $272M | Buy |
599,700
+51,500
| +9% | +$24.6M | 0.06% | 207 |
|
|
2022
Q2 | $265M | Buy |
548,200
+333,200
| +155% | +$165M | 0.07% | 199 |
|
|
2022
Q1 | $106M | Buy |
215,000
+59,400
| +38% | +$27.2M | 0.02% | 634 |
|
|
2021
Q4 | $72.1M | Sell |
155,600
-84,700
| -35% | -$35.6M | 0.01% | 891 |
|
|
2021
Q3 | $89.6M | Buy |
240,300
+41,000
| +21% | +$15.6M | 0.02% | 719 |
|
|
2021
Q2 | $76.1M | Buy |
199,300
+35,900
| +22% | +$13.7M | 0.02% | 831 |
|
|
2021
Q1 | $58.7M | Buy |
163,400
+45,000
| +38% | +$14.5M | 0.01% | 921 |
|
|
2020
Q4 | $38M | Sell |
118,400
-135,900
| -53% | -$41.7M | 0.01% | 1186 |
|
|
2020
Q3 | $68.3M | Buy |
254,300
+25,800
| +11% | +$6.94M | 0.02% | 669 |
|
|
2020
Q2 | $60.1M | Sell |
228,500
-39,000
| -15% | -$10.4M | 0.02% | 689 |
|
|
2020
Q1 | $60.7M | Sell |
267,500
-4,600
| -2% | -$1.25M | 0.03% | 558 |
|
|
2019
Q4 | $82.2M | Sell |
272,100
-15,300
| -5% | -$4.21M | 0.04% | 501 |
|
|
2019
Q3 | $69M | Sell |
287,400
-23,800
| -8% | -$6.52M | 0.03% | 577 |
|
|
2019
Q2 | $87.8M | Buy |
311,200
+131,300
| +73% | +$35.9M | 0.04% | 449 |
|
|
2019
Q1 | $51.6M | Sell |
179,900
-11,400
| -6% | -$3.3M | 0.03% | 674 |
|
|
2018
Q4 | $50.2M | Sell |
191,300
-94,100
| -33% | -$25.9M | 0.03% | 616 |
|
|
2018
Q3 | $78.2M | Buy |
285,400
+160,800
| +129% | +$41.7M | 0.03% | 521 |
|
|
2018
Q2 | $29.7M | Sell |
124,600
-4,100
| -3% | -$949K | 0.01% | 1000 |
|
|
2018
Q1 | $28.3M | Buy |
128,700
+80,100
| +165% | +$18.8M | 0.02% | 881 |
|
|
2017
Q4 | $10.9M | Sell |
48,600
-9,800
| -17% | -$2.09M | 0.01% | 1640 |
|
|
2017
Q3 | $11.1M | Buy |
58,400
+3,800
| +7% | +$723K | 0.01% | 1509 |
|
|
2017
Q2 | $10.3M | Sell |
54,600
-3,800
| -7% | -$683K | 0.01% | 1439 |
|
|
2017
Q1 | $9.66M | Sell |
58,400
-20,200
| -26% | -$3.21M | 0.01% | 1470 |
|
|
2016
Q4 | $11.3M | Buy |
78,600
+11,400
| +17% | +$1.53M | 0.01% | 1264 |
|
|
2016
Q3 | $8.42M | Buy |
67,200
+2,500
| +4% | +$323K | 0.01% | 1518 |
|
|
2016
Q2 | $8.5M | Sell |
64,700
-7,100
| -10% | -$971K | 0.01% | 1370 |
|
|
2016
Q1 | $9.98M | Sell |
71,800
-25,800
| -26% | -$3.45M | 0.01% | 1197 |
|
|
2015
Q4 | $13.6M | Sell |
97,600
-5,300
| -5% | -$730K | 0.01% | 1062 |
|
|
2015
Q3 | $14.4M | Buy |
102,900
+22,500
| +28% | +$3.38M | 0.01% | 1113 |
|
|
2015
Q2 | $13.2M | Buy |
80,400
+17,600
| +28% | +$2.81M | 0.01% | 1281 |
|
|
2015
Q1 | $9.7M | Sell |
62,800
-16,600
| -21% | -$2.36M | 0.01% | 1485 |
|
|
2014
Q4 | $9.98M | Sell |
79,400
-9,000
| -10% | -$1.11M | 0.01% | 1405 |
|
|
2014
Q3 | $10.6M | Buy |
88,400
+20,100
| +29% | +$2.31M | 0.01% | 1324 |
|
|
2014
Q2 | $7.35M | Sell |
68,300
-33,600
| -33% | -$3.46M | 0.01% | 1516 |
|
|
2014
Q1 | $10.1M | Buy |
101,900
+7,700
| +8% | +$696K | 0.01% | 1253 |
|
|
2013
Q4 | $8.7M | Sell |
94,200
-53,400
| -36% | -$4.74M | 0.01% | 1301 |
|
|
2013
Q3 | $12.3M | Sell |
147,600
-18,700
| -11% | -$1.6M | 0.02% | 984 |
|
|
2013
Q2 | $13.6M | Buy |
+166,300
| New | +$12.4M | 0.02% | 871 |
|
Other funds holding ELV
VCM
VPM
Citadel Advisors's ELV Position: Q1 2026 in Review
Citadel Advisors reduced its Elevance Health (ELV) stake by 6.3% in Q1 2026, selling an estimated $34.8M and leaving 1,562,219 shares worth $457M. The position accounts for 0.07% of the portfolio, ranked #199.
Citadel Advisors first reported a position in ELV in Q2 2013 and has held it in 49 quarters since. The position peaked at $585M in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Citadel Advisors held 1,562,219 shares of Elevance Health worth $457M as of Q1 2026.
- Citadel Advisors sold 105,850 Elevance Health shares in Q1 2026, an estimated $34.8M.
- Elevance Health made up 0.07% of Citadel Advisors's portfolio in Q1 2026, its #199 holding.
- Citadel Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 49 quarters since.
- Citadel Advisors's Elevance Health position peaked at $585M in Q4 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.